Compare Amylx Pharmaceuticals Inc (AMLX) vs Cintas Corporation (CTAS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amylx Pharmaceuticals Inc vs Cintas Corporation — how do they compare? Amylx Pharmaceuticals Inc trades at $23.65 (market cap $2.64B), while Cintas Corporation trades at $205.28 (market cap $82.15B). The key difference: Cintas Corporation is far larger — about 31.1× Amylx Pharmaceuticals Inc's market cap, and Cintas Corporation pays a 1.01% dividend while Amylx Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMLX | CTAS | |
|---|---|---|
Market Cap | $2.64B | $82.15B |
Sector | Health | Industrials |
52-Week High | $24.19 | $225.10 |
52-Week Low | $7.82 | $163.55 |
Enterprise Value | $2.39B | $84.56B |
Dividend Yield | — | 1.01% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amylx Pharmaceuticals Inc
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →About Cintas Corporation
In its core uniform and facility services unit (78% of sales), Cintas provides uniform rental programs to businesses across the size spectrum, mostly in North America. The firm is by far the largest provider in the industry. Facilities products generally include the rental and sale of entrance mat, mops, shop towels, hand sanitizers, and restroom supplies. Cintas also runs a first aid and safety services business (11% of sales), a fire protection services business (7% of sales), and a uniform direct sales business (4% of sales).
Read more on CTAS →
